Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 69 Records) |
Query Trace: Breast Neoplasms and Mdm2[original query] |
---|
Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility. PloS one 2014 8 (6): e64896. Sapkota Yadav, Mackey John R, Lai Raymond, Franco-Villalobos Conrado, Lupichuk Sasha, Robson Paula J, Kopciuk Karen, Cass Carol E, Yasui Yutaka, Damaraju Sambasivar |
Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial. The pharmacogenomics journal 2015 Feb 15 (1): 63-8. Le Morvan V, Litière S, Laroche-Clary A, Ait-Ouferoukh S, Bellott R, Messina C, Cameron D, Bonnefoi H, Robert |
TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jul 20 (13): 3569-80. Silwal-Pandit Laxmi, Vollan Hans Kristian Moen, Chin Suet-Feung, Rueda Oscar M, McKinney Steven, Osako Tomo, Quigley David A, Kristensen Vessela N, Aparicio Samuel, Børresen-Dale Anne-Lise, Caldas Carlos, Langerød Ani |
Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: a meta-analysis based on 9,788 cases and 11,195 controls. Therapeutics and clinical risk management 2014 10 269-77. Gao Jie, Kang An-Jing, Lin Shuai, Dai Zhi-Jun, Zhang Shu-Qun, Liu Di, Zhao Yang, Yang Peng-Tao, Wang Meng, Wang Xi-Ji |
Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon. International journal of cancer. Journal international du cancer 2015 Jul 137 (1): 96-103. Gansmo Liv B, Knappskog Stian, Romundstad Pål, Hveem Kristian, Vatten Lars, Lønning Per |
A 40-bp insertion/deletion polymorphism of Murine Double Minute2 (MDM2) increased the risk of breast cancer in Zahedan, Southeast Iran. Iranian biomedical journal 2014 18 (4): 245-9. Hashemi Mohammad, Omrani Mohsen, Eskandari-Nasab Ebrahim, Hasani Seyed-Shahaboddin, Mashhadi Mohammad Ali, Taheri Mohs |
Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2015 Nov . Yadav P, Masroor M, Tanwer K, Mir R, Javid J, Ahmad I, Zuberi M, Kaza R C M, Jain S K, Khurana N, Ray P C, Saxena |
MDM4 SNP34091 (rs4245739) and its effect on breast-, colon-, lung-, and prostate cancer risk. Cancer medicine 2015 Oct . Gansmo Liv B, Romundstad Pål, Birkeland Einar, Hveem Kristian, Vatten Lars, Knappskog Stian, Lønning Per Eyste |
MDM2 344T>A polymorphism; could it be a predictive marker of anthracycline resistance? Journal of B.U.ON. : official journal of the Balkan Union of Oncology 0 21 (3): 732-9. Arfaoui Abir, Douik Hayet, Kablouti Ghalia, Chaaben Arijben, Handiri Nadia, Zid Zaineb, Ouni Nesrine, Zouiouch Farah, Ayari Fayza, Mamoghli Tensime, Bouassida Jihen, Harzallah Latifa, Guemira Fet |
Assessment of TP53 Polymorphisms and MDM2 SNP309 in Premenopausal Breast Cancer Risk. Human mutation 2016 Dec . Samuel Nardin, Id Said Badr, Guha Tanya, Novokmet Ana, Li Weili, Silwal-Pandit Laxmi, Børrsen-Dale Anne-Lise, Langerød Anita, Hudson Thomas J, Malkin Dav |
p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers. Familial cancer 2017 Jul . Macedo Gabriel S, Vieira Igor Araujo, Vianna Fernanda Salles Luiz, Alemar Barbara, Giacomazzi Juliana, Brandalize Ana Paula Carneiro, Caleffi Maira, Volc Sahlua Miguel, de Campos Reis Galvão Henrique, Palmero Edenir Inez, Achatz Maria Isabel, Ashton-Prolla Patric |
Association of the Del1518 Promoter (rs3730485) Polymorphism in the MDM2 Gene with Breast Cancer in a Mexican Population. Annals of clinical and laboratory science 2017 May 47 (3): 291-297. Gallegos-Arreola Martha Patricia, Márquez-Rosales María Guadalupe, Sánchez-Corona José, Figuera Luis Eduardo, Zúñiga-González Guillermo, Puebla-Pérez Ana María, Delgado-Saucedo Jorge Iván, Montoya-Fuentes Héct |
Lack of an Association between a Functional Polymorphism in the MDM2 Promoter and Breast Cancer in Women in Northeast Iran. Reports of biochemistry & molecular biology 2017 Oct 6 (1): 112-117. Tavakkol Afshari Zeinab, Nikpoor Amin Reza, Tavakkol Afshari Jalil, Ganjali Rashin, Sanglakh Ghoochan Atigh Parvaneh, Homaei Shandiz Fatemeh, Jamialahmadi Khadij |
The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females. BMC cancer 2017 Nov 17 (1): 758. Isakova Jainagul, Talaibekova Elnura, Aldasheva Nazira, Vinnikov Denis, Aldashev Alm |
Significant Association of the MDM2 T309G Polymorphism with Breast Cancer Risk in a Turkish Population. Asian Pacific journal of cancer prevention : APJCP 2018 Apr 19 (4): 1059-1062. Yilmaz Meral, Tas Ayca, Donmez Gonca, Kacan Turgut, Silig Yav |
The molecular genetic make-up of male breast cancer. Endocrine-related cancer 2019 Jul . Moelans Cathy B, de Ligt Joep, van der Groep Petra, Prins Pjotr, Besselink Nicolle J M, Hoogstraat Marlous, Ter Hoeve Natalie D, Lacle Miangela M, Kornegoor Robert, van der Pol Carmen C, de Leng Wendy W J, Barbé Ellis, van der Vegt Bert, Martens John, Bult Peter, Smit Vincent T H B M, Koudijs Marco J, Nijman Isaac J, Voest Emile E, Selenica Pier, Weigelt Britta, Reis-Filho Jorge S, van der Wall Elsken, Cuppen Edwin, van Diest Paul |
Specific allelic variants of SNPs in the MDM2 and MDMX genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients. Oncotarget 2019 Mar 10 (20): 1975-1992. Bauer Marcus, Kantelhardt Eva Johanna, Stiewe Thorsten, Nist Andrea, Mernberger Marco, Politt Katharina, Hanf Volker, Lantzsch Tilmann, Uleer Christoph, Peschel Susanne, John Jutta, Buchmann Jörg, Weigert Edith, Bürrig Karl-Friedrich, Wickenhauser Claudia, Thomssen Christoph, Bartel Frank, Vetter Marti |
P21 Ser31Arg and FGFR2 rs2981582 Polymorphisms as Risk Factors for Early Onset of Breast Cancer in Yogyakarta, Indonesia. Asian Pacific journal of cancer prevention : APJCP 2019 Nov 20 (11): 3305-3309. Purnomosari Dewajani, Raharjo Clarista, Kalim Alvin Santoso, Herviastuti Rahma, Yushan Markus, Fajar Rangga Athilah, Harris Karina Kazia, Wahyono Artan |
Association of the MDM2 SNP285 and SNP309 Genetic Variants with the Risk, Age at Onset and Prognosis of Breast Cancer in Central European Women: A Hospital-Based Case-Control Study. International journal of molecular sciences 2019 1 20 (3): . Miedl Heidi, Lebhard Jürgen, Ehart Lisa, Schreiber Mart |
A case-control study on the SNP309T ? G and 40-bp Del1518 of the MDM2 gene and a systematic review for MDM2 polymorphisms in the patients with breast cancer. Journal of clinical laboratory analysis 2020 9 34 (12): e23529. Jalilvand Amin, Yari Kheirollah, Aznab Mozaffar, Rahimi Zohreh, Salahshouri Far Iman, Mohammadi Pant |
Gene-to-gene interactions and the association of TP53, XRCC1, TNF?, HMMR, MDM2 and PALB2 with breast cancer in Kyrgyz females. Breast cancer (Tokyo, Japan) 2020 Apr . Isakova J T, Vinnikov D, Kipen V N, Talaibekova E T, Aldashev A A, Aldasheva N M, Makieva K B, Semetei Kyzy A, Bukuev N M, Tilekov E A, Shaimbetov B O, Kudaibergenova I |
Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients. BMC cancer 2020 Jan 20 (1): 72. Manoharan Vahinipriya, Karunanayake Eric Hamilton, Tennekoon Kamani Hemamala, De Silva Sumadee, Imthikab Ahamed Ilyas Ahamed, De Silva Kanishka, Angunawela Preethika, Vishwakula Sameera, Lunec Jo |
The 40bp Indel Polymorphism rs150550023 in the MDM2 Promoter is Associated with Intriguing Shifts in Gene Expression in the p53-MDM2 Regulatory Hub. Cancers 2020 Nov 12 (11): . Miedl Heidi, Dietrich Bianca, Kaserer Klaus, Schreiber Mart |
Murine Double Minute 2 Gene (MDM2) rs937283A/G variant significantly increases the susceptibility to breast cancer in Saudi Women. Saudi journal of biological sciences 2021 4 28 (4): 2272-2277. Shebli Weam Talal Yehya, Alotibi Mohammad Kdaimes H, Al-Raddadi Rawya Ibrahim, Al-Amri Razan Jamaan, Fallatah Emad Ibrahim Yagoub, Alhujaily Ahmed Safar, Mohamed Hiba Salaheld |
Associations of MDM2 and MDM4 Polymorphisms with Early-Stage Breast Cancer. Journal of clinical medicine 2021 Feb 10 (4): . Bartnykait? Agn?, Savukaityt? Aist?, Ugenskien? Rasa, Daukšait? Monika, Korobeinikova Erika, Gudaitien? Jurgita, Juozaityt? Elo |
Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses. BMC cancer 2021 2 21 (1): 199. Huang Chi-Cheng, Tsai Yi-Fang, Liu Chun-Yu, Chao Ta-Chung, Lien Pei-Ju, Lin Yen-Shu, Feng Chin-Jung, Chiu Jen-Hwey, Hsu Chih-Yi, Tseng Ling-Mi |
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers. Communications biology 2022 4 5 (1): 373. Bianco Gaia, Coto-Llerena Mairene, Gallon John, Kancherla Venkatesh, Taha-Mehlitz Stephanie, Marinucci Mattia, Konantz Martina, Srivatsa Sumana, Montazeri Hesam, Panebianco Federica, Tirunagaru Vijaya G, De Menna Marta, Paradiso Viola, Ercan Caner, Dahmani Ahmed, Montaudon Elodie, Beerenwinkel Niko, Kruithof-de Julio Marianna, Terracciano Luigi M, Lengerke Claudia, Jeselsohn Rinath M, Doebele Robert C, Bidard François-Clément, Marangoni Elisabetta, Ng Charlotte K Y, Piscuoglio Salvato |
Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials. Annals of oncology : official journal of the European Society for Medical Oncology 2023 9 . F André, F Su, N Solovieff, G Hortobagyi, S Chia, P Neven, A Bardia, D Tripathy, Y-S Lu, A Lteif, T Taran, N Babbar, D Slamon, C L Artea |
Clinical and Genomic Characteristics of Patients with HR+, HER2- Metastatic Breast Cancer Following Progression on a CDK4 and 6 Inhibitor. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 6 . Xi Rao, Yongmei Chen, Julie Beyrer, Emily Nash Smyth, Claudia Morato Guimaraes, Lacey M Litchfield, Lee Bowman, Garreth W Lawrence, Amit Aggarwal, Fabrice And |
Identification of MDM2 as a prognostic and immunotherapeutic biomarker in a comprehensive pan-cancer analysis: A promising target for breast cancer, bladder cancer and ovarian cancer immunotherapy. Life sciences 2023 6 121832. Jialiang Zheng, Fenglin Miao, Zhao Wang, Yuan Ma, Zhenhang Lin, Yaqin Chen, Xu Kong, Yue Wang, Aobo Zhuang, Ting Wu, Wengang |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: